| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Revenue | $2.76B | +2.5% |
| Cost of Revenue | $2.01B | -2.7% |
| R&D Expense | $25.0M | +0.0% |
| SG&A Expense | $662.0M | +19.1% |
| Operating Income | $92.0M | +22.7% |
| Interest Expense | $10.0M | — |
| Pre-tax Income | $145.0M | +657.7% |
| Income Tax | $35.0M | +3600.0% |
| Net Income | $110.0M | +540.0% |
| EPS (Basic) | $1.28 | +541.4% |
| EPS (Diluted) | $1.28 | +541.4% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.0M | — |
| Accounts Receivable | $244.0M | +6.6% |
| Inventory | $345.0M | -20.0% |
| Current Assets | $706.0M | +5.4% |
| Total Assets | $1.89B | +31.5% |
| Current Liabilities | $836.0M | +25.5% |
| Long-term Debt | $487.0M | — |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $422.0M | +696.2% |
| Capital Expenditures | $150.0M | +111.3% |
| Investing Cash Flow | -$146.0M | -105.6% |
| Financing Cash Flow | -$188.0M | -1144.4% |
| Free Cash Flow | $272.0M | +1611.1% |
| Stockholders' Equity |
| $300.0M |
| -56.3% |